Already in an early clinical study with autologous T cells expressing a CAR directed toward carbonic anhydrase IX, an antigen highly expressed in renal cell carcinoma, we have reported distinct humoral and cellular anti-CAR responses in combination with limited peripheral persistence of transferred CAR T cells [36,37]. Here, CA9 is linked to renal cell carcinoma.